174 episodes

The cannabis industry is gaining traction across the world, as new medical discoveries, and multi-billion dollar businesses are grabbing the headlines on a regular basis. Experts predict the worldwide industry could be worth in excess of $300bn within 10 years, with Europe forming the biggest market within that, so there's plenty to get excited about. I want to find out more about what's happening, and I'm bringing you along for the ride. Join me - Anuj Desai - as I speak to a wide variety of guests who are helping to shape this nascent sector. Having interviewed over 100 guests, including patients, lawyers, doctors, scientists, entrepreneurs, investors and many more, we discover how, and why, this much maligned and misunderstood plant is giving birth to a huge global business.

The Cannabis Conversation | Medical Cannabis | CBD | Hemp Anuj Desai

    • Business
    • 4.9 • 14 Ratings

The cannabis industry is gaining traction across the world, as new medical discoveries, and multi-billion dollar businesses are grabbing the headlines on a regular basis. Experts predict the worldwide industry could be worth in excess of $300bn within 10 years, with Europe forming the biggest market within that, so there's plenty to get excited about. I want to find out more about what's happening, and I'm bringing you along for the ride. Join me - Anuj Desai - as I speak to a wide variety of guests who are helping to shape this nascent sector. Having interviewed over 100 guests, including patients, lawyers, doctors, scientists, entrepreneurs, investors and many more, we discover how, and why, this much maligned and misunderstood plant is giving birth to a huge global business.

    EPISODE #174: Cannabis Genetics and Breeding with Dr Gavin George, Co-founder of Puregene AG

    EPISODE #174: Cannabis Genetics and Breeding with Dr Gavin George, Co-founder of Puregene AG

    How can we get the most out of the cannabis plant?
    On the latest episode of The Cannabis Conversation, we speak with Dr Gavin George, CEO of Puregene AG - a Swiss company specialising in genomics and predictive plant breeding.
    We explore the potential of cannabis to produce hundreds of different products, including the challenges that come with it. We also explore the process of plant breeding, how much scope the cannabis plant has to evolve, and some of the new technologies needed to maximise this potential.


    The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
    Get in touch at www.luminorecruit.com/

    About Dr Gavin George
    Dr. Gavin George is a Cofounder of Puregene AG and previously held the position of Director of Research and Intellectual Property, before being appointed to CEO.
    Dr. George was awarded a PhD in Plant Biotechnology in 2010 from the Institute for Plant Biotechnology at the University of Stellenbosch, South Africa.
    He subsequently worked for 7 years at the ETH Zurich as a Postdoctoral Researcher where he investigated the relationship between internal and external factors on plant growth.
    He has authored 14 peer reviewed publications and contributed to 3 books. 
    His research was focused on the improvement of various crop species including sugarcane, tobacco, tomato, and potato as well as the creation of research devices for the detailed measurement of phenotypic traits.
    As the Director of Research and IP at Puregene, he ensured that the high-throughput analytical, phenotyping, biochemistry and sequencing technology platforms optimally support the breeding activities and global intellectual property pipelines of Puregene.
    As CEO he is focused on working with more international commercial partners and academic institutes for the development of new markets for cannabis and hemp genetics and the deployment of complete breeding programs.


    Resources
    Connect with Dr Gavin George on LinkedIn: https://www.linkedin.com/company/puregene-ag/
    Puregene AG’s Website: www.puregene.com
    Follow Dr Gavin on Instagram: @puregeneag 
    Follow Dr Gavin on Twitter: @puregene

    • 42 min
    EPISODE #173: What's Wrong With The Cannabis Industry? with Dr. Ethan Russo, Founder of Credo Science

    EPISODE #173: What's Wrong With The Cannabis Industry? with Dr. Ethan Russo, Founder of Credo Science

    What’s wrong with the cannabis industry?
    Joining us again on the latest episode of The Cannabis Conversation is Dr Ethan Russo, Founder of Credo Science -  a novel medical science company.

    We discuss the prejudice and ignorance against Cannabis, as well as safety monitoring, legalisation and some of the challenges the industry is facing, including a lack of proper funded research in the area.


    The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
    Get in touch at www.luminorecruit.com/


    About Ethan Russo
    Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Founder/CEO of CReDO Science https://credo-science.com 


    He is also Medical Director of Andira Pharmaceuticals Andira – Bringing Healing to Life and Senior Medical Advisor to Canurta Home | Canurta


    Previously he was Director of Research and Development for the International Cannabis and Cannabinoids Institute, 2017-19, Medical Director of PHYTECS, 2015-2017, and from 2003-2014, Senior Medical Advisor, medical monitor/study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® and Epidiolex®.


    He was a clinical neurologist in Missoula, Montana for 20 years. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, and in Medicine at the University of Washington. He is author/editor of seven books and has published more than 50 peer-reviewed articles.



    Resources
    Join Dr. Russo on LinkedIn: https://www.linkedin.com/in/ethan-russo-md-468b19a/
    View Dr. Russo’s clinical research papers: https://www.researchgate.net/profile/Ethan_Russo
    CReDO Science Website: https://credo-science.com/

    • 44 min
    EPISODE #172: Medical Cannabis Patients with Mags Houston, Matt Hughes, Hannah Deacon, & Mary Biles

    EPISODE #172: Medical Cannabis Patients with Mags Houston, Matt Hughes, Hannah Deacon, & Mary Biles

    In this week’s episode, we’re joined by Mags Houston from Drug Science, Mary Biles (author of The CBD Book), Matt Hughes from MedCan Support, and Hannah Deacon from The Medical Cannabis Clinicians Society to discuss the upcoming UK Patient Conference on 4th Nov in London. 
    We discuss the importance of patient conferences to patients themselves, parents, and anyone interested in learning more about cannabis-based medicines.


    The upcoming conference will feature talks from some of the leading experts in the field, as well as opportunities to learn about patient experiences, the latest research, and developments. Whether you're new to the topic or have been following the medical cannabis debate for some time, this is a great opportunity to get involved and learn more. 
    This promises to be a fascinating and informative event, so if you are a patient or interested in medical cannabis then make sure you register for free today for the livestream - unfortunately in-person tickets are all sold out!
    Date and time: Fri, 4 Nov 2022, 10:30 – 18:30 GMT
    Tickets are available through this link: UK Patience Conference


    The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
    Get in touch at www.luminorecruit.com/


    About Our Guests
    Mags Houston
    As Head of Projects & Comms for Drug Science, Mags oversees the running of Drug Science’s medical cannabis observational study, Project Twenty21. The study helps to raise awareness of medical cannabis, building more evidence by attracting more patients and prescribers to actively join the project, and educating the public about the growing evidence surrounding medical cannabis for treating a range of conditions. 


    Matt Hughes
    Having campaigned for NHS access to prescription his son Charlie since 2019 and the knowledge he gained through experience, In collaboration with Hannah Deacon, Matt formed MedCan Support, having felt there was a gap in education for parents, carers and families. Building a central forum to educate and inform parents and carers so they can work with their doctors to make informed decisions on their loved ones care. To provide a safe space for parents and carers to ask questions about prescription cannabis and feel confident to advocate for their child or family members health care needs.


    Hannah Deacon
    Medical cannabis expert & campaigner Hannah Deacon is one of the most influential and high-profile female leaders in the UK's medical cannabis sector.With an international reputation for pioneering change, as a dedicated patient advocate, Hannah also works to overcome barriers to medical cannabis treatment in the UK, supporting better education for doctors so patients across the country get the access they need.


    Mary Biles
    Mary Biles is the author of The CBD Book, a regular contributor to Project CBD and host of the podcast Cannabis Voices. She is a vocal advocate of greater access to medicinal cannabis for patients and fostering an industry where patients' needs are firmly held at the centre of companies' business models.

    • 32 min
    EPISODE #171 Holistic Health and Cannabis with Dr Dani Gordon, Founder and Medical Director of Resilience.Clinic

    EPISODE #171 Holistic Health and Cannabis with Dr Dani Gordon, Founder and Medical Director of Resilience.Clinic

    This week we’re joined by Dr Dani Gordon, Founder and Medical Director of Resilience.Clinic - specialising in the treatment of complex multi-symptom conditions which affect mood, energy, mental function (brain fog), stress, pain, sleep, and digestion.
    Together, we explore some of the conditions medical cannabis can help with, the non-medical interventions that form part of a holistic health regime, and how medical cannabis can play a part in that.


    The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
    Get in touch at www.luminorecruit.com/


    About Dr Dani Gordon
    Dr Dani Gordon MD is a double board certified integrative medicine physician and leading expert in integrative and cannabinoid medicine, and resilience. She has treated thousands of patients with medical cannabis, is vice chair of the UK Medical Cannabis Clinicians Society and is author of ‘The CBD Bible.’ She is the founder and Medical Director of Resilience.Clinic, her UK medical practice and wellbeing platform with a focus on mental health, chronic fatigue and complex chronic disease. She is regularly interviewed for TV and the media and has been featured in the Sunday Times, The Guardian, BBC, Vogue and Marie Claire.


    Resources
    Connect with Dr Dani Gordon on LinkedIn: https://www.linkedin.com/in/drdanigordon/
    Follow Dr Dani on Twitter: https://twitter.com/drdanigordon
    Follow Dr Dani on Instagram: https://www.instagram.com/drdanigordon/
    Subscribe Dr Dani on Youtube: https://www.youtube.com/user/DrDaniMD
    Resilience Medicine Clinics’ website: https://resiliencemedicine.clinic/

    • 33 min
    EPISODE #170 Cannabis Conferences and Events with Ben Arn, CEO of Cannatrade and CB Company

    EPISODE #170 Cannabis Conferences and Events with Ben Arn, CEO of Cannatrade and CB Company

    Joining us on the latest episode of The Cannabis Conversation is Ben Arn, CEO of Cannatrade and CB Company - cannabis events companies based in Switzerland. 
    Ben gives us a round-up of the latest Swiss cannabis industry news, and we also discuss the crucial role that events and conferences play, not only in driving the cannabis industry forwards, but expanding education and reducing stigma.


    📚 VIEW SHOW NOTES AND EXTRAS:
    www.canverse.global/shownotes/e170


    The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
    Get in touch at www.luminorecruit.com/



    About Ben Arn
    Ben has been the organizer of Cannabis Events in Switzerland since 2006. His projects also include CannaTrade - International Cannabis Expo (b2c and b2b) in Bern, the CB Expo - Cannabis Business Expo (b2b) and the CB Club - Cannabis Business Network event in Zurich. In 2022 he is also organising the Cannabinoid Conference 2022 (12th IACM Conference and 1 st SSCm Confernce) in Basel. His passions are organising events and connecting people, and the enormous potential of the cannabis plant.


    Timestamps
    0:00 Welcome to The Cannabis Conversation
    0:58 Introduction to Ben and how he got into the cannabis industry
    2:40 How Ben became involved in Cannatrade
    3:59 Switzerland’s new medical cannabis laws and pilot projects
    4:27 An overview of the current state of play in Switzerland regarding cannabis products
    7:12 Recreational cannabis trials in Switzerland in 2022
    9:50 About Cannatrade, CB Expo and CB Club
    14:25 How important are events and conferences for an emerging industry like cannabis?
    17:39 What are the differences between big events and smaller intimate ones?
    22:00 Do you have any networking tips or tricks?
    24:11 How important it is to get people from outside the industry coming to conferences to learn more about what's happening?


    Resources
    Follow CannaTrade on LinkedIn: https://www.linkedin.com/company/cannatrade/
    Follow CB Company on LinkedIn: https://www.linkedin.com/company/71937276/
    Follow Cannabis Medicinalis on LinkedIn: https://www.linkedin.com/company/cannabis-medicinalis

    • 29 min
    EPISODE #169 Clinical and Pre-Clinical Cannabinoid Research with Dr. Mikael Sodergren, Managing Director at Sapphire Medical Clinics

    EPISODE #169 Clinical and Pre-Clinical Cannabinoid Research with Dr. Mikael Sodergren, Managing Director at Sapphire Medical Clinics

    In our latest episode, we welcome Dr. Mikael Sodergren, Medical Cannabis Research Group Lead at Imperial College London and Managing Director at Sapphire Medical Clinics.


    We examine how clinical trials and real-world evidence can be used to prove the efficacy of cannabis-based medicines, as well as the challenges associated with applying traditional licensing and regulatory models to these novel medicines.



    📚 VIEW SHOW NOTES AND EXTRAS:


    www.canverse.global/shownotes/e169




    The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.


    Get in touch at www.luminorecruit.com/




    About Mikael Sodergren


    Dr Mikael Sodergren MBChB(Hons) DIC PhD FRCS, is a Clinical Senior Lecturer at Imperial College London where he leads the Medical Cannabis Research Group. He is co-founder of Sapphire Medical Clinics, the first medical cannabis clinic approved by the CQC in England, and Chief Medical Officer at Curaleaf International. 





    Timestamps


    0:00 Welcome to The Cannabis Conversation


    1:08 Introduction to Dr. Mikael Sodergren and his clinical work as a surgeon within oncology


    3:48 Dr. Sodergren’s initial research into the use of CBD in cancer treatment and interest in medical cannabis


    5:43 Dr. Sodergren’s current research into pain pathways and the use of cannabis to combat acute and chronic pain


    7:57 Imperial College London and its progressive research within cannabis (and psychadelics)


    09:35 Have you ever encountered any stigma from peers or colleagues?


    11:02 The founding of Sapphire Medical Clinics


    13:30 How does the process of clinical research work?


    18:12 How are regulators involved in the process?


    19:04 Preclinical research and what is involved


    20:21 What challenges are involved with cannabis drug development?


    26:33 Randomised controlled trials and their use within medical cannabis development


    29:59 Clinical trials vs. real world evidence


    31:48 How do you feel about the use of cannabis flower as a medicine?


    33:33 What factors can help accelerate medical cannabis research?




    Resources


    Sapphire Medical Clinics’ Website: https://www.sapphireclinics.com/


    Follow Sapphire Medical Clinics on LinkedIn: https://www.linkedin.com/company/sapphire-medical-clinics/


    More about the Medical Cannabis Research Group at Imperial College London: 

    • 39 min

Customer Reviews

4.9 out of 5
14 Ratings

14 Ratings

oliviabaker13 ,

Educational, engaging, and insightful 🙏

Whether you’re a canna-sseur or just canna-curious - this is a must-listen podcast! Anuj is an excellent host and does a fantastic job leading conversations with thought leaders, scientists, and other experts in the cannabis space. This is an engaging and professional show that covers global legal and business trends, new medical and scientific developments, and the many positives of cannabis! Highly recommend listening and subscribing.

Top Podcasts In Business

Ramsey Network
NPR
Jocko DEFCOR Network
Marketplace
Andy Frisella #100to0
Guy Raz | Wondery

You Might Also Like

Tad Hussey
Abdullah Saeed and David Bienenstock
Natural Learning Enterprises, LLC
Jordan River
BBC Radio 4
Andrew Dowling and Mitch Kurz